Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection.

Mrozek-Gorska P, Buschle A, Pich D, Schwarzmayr T, Fechtner R, Scialdone A, Hammerschmidt W.

Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):16046-16055. doi: 10.1073/pnas.1901314116. Epub 2019 Jul 24.

2.

First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus.

Pich D, Mrozek-Gorska P, Bouvet M, Sugimoto A, Akidil E, Grundhoff A, Hamperl S, Ling PD, Hammerschmidt W.

MBio. 2019 Sep 17;10(5). pii: e01723-19. doi: 10.1128/mBio.01723-19.

3.

Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.

Kalla M, Hammerschmidt W.

Eur J Cell Biol. 2012 Jan;91(1):65-9. doi: 10.1016/j.ejcb.2011.01.014. Epub 2011 Mar 29. Review.

PMID:
21450364
4.
5.

EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency.

Styles CT, Bazot Q, Parker GA, White RE, Paschos K, Allday MJ.

PLoS Biol. 2017 Aug 3;15(8):e2001992. doi: 10.1371/journal.pbio.2001992. eCollection 2017 Aug.

6.

Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines.

Grossman L, Chang C, Dai J, Nikitin PA, Jima DD, Dave SS, Luftig MA.

mSphere. 2017 Nov 29;2(6). pii: e00305-17. doi: 10.1128/mSphere.00305-17. eCollection 2017 Nov-Dec.

7.

RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes.

Wang C, Li D, Zhang L, Jiang S, Liang J, Narita Y, Hou I, Zhong Q, Zheng Z, Xiao H, Gewurz BE, Teng M, Zhao B.

J Virol. 2019 Jun 14;93(13). pii: e00226-19. doi: 10.1128/JVI.00226-19. Print 2019 Jul 1.

PMID:
31019051
8.

The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites.

Kalla M, Göbel C, Hammerschmidt W.

J Virol. 2012 Jan;86(1):447-58. doi: 10.1128/JVI.06314-11. Epub 2011 Oct 26.

9.

Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions.

Rowe M, Raithatha S, Shannon-Lowe C.

J Virol. 2014 Oct;88(20):12065-76. doi: 10.1128/JVI.01431-14. Epub 2014 Aug 13.

10.

Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.

Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM, Kieff E.

J Virol. 2004 Apr;78(8):4108-19.

11.

Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis.

Altmann M, Hammerschmidt W.

PLoS Biol. 2005 Dec;3(12):e404. Epub 2005 Nov 15.

12.

Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the STK39 Gene in B Cells Infected by EBV.

Bazot Q, Paschos K, Allday MJ.

J Virol. 2018 Mar 14;92(7). pii: e01918-17. doi: 10.1128/JVI.01918-17. Print 2018 Apr 1.

13.

Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation.

Price AM, Luftig MA.

Adv Virus Res. 2014;88:279-313. doi: 10.1016/B978-0-12-800098-4.00006-4. Review.

14.

c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.

Price AM, Messinger JE, Luftig MA.

J Virol. 2018 Jan 2;92(2). pii: e01178-17. doi: 10.1128/JVI.01178-17. Print 2018 Jan 15.

15.

Restricted expression of Epstein-Barr virus latent genes in murine B cells derived from embryonic stem cells.

Zychlinska M, Herrmann H, Zimber-Strobl U, Hammerschmidt W.

PLoS One. 2008 Apr 16;3(4):e1996. doi: 10.1371/journal.pone.0001996.

16.

Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency.

Wille CK, Li Y, Rui L, Johannsen EC, Kenney SC.

J Virol. 2017 Feb 14;91(5). pii: e01987-16. doi: 10.1128/JVI.01987-16. Print 2017 Mar 1.

17.

AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.

Kalla M, Schmeinck A, Bergbauer M, Pich D, Hammerschmidt W.

Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):850-5. doi: 10.1073/pnas.0911948107. Epub 2009 Dec 22.

18.

Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation.

Smith N, Tierney R, Wei W, Vockerodt M, Murray PG, Woodman CB, Rowe M.

PLoS One. 2013 May 27;8(5):e64868. doi: 10.1371/journal.pone.0064868. Print 2013.

19.

Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.

Ma SD, Tsai MH, Romero-Masters JC, Ranheim EA, Huebner SM, Bristol JA, Delecluse HJ, Kenney SC.

J Virol. 2017 Mar 13;91(7). pii: e01928-16. doi: 10.1128/JVI.01928-16. Print 2017 Apr 1.

20.

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

Niller HH, Wolf H, Minarovits J.

Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Review.

PMID:
18432410

Supplemental Content

Support Center